Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY

Mid Cap | Pharmaceuticals & Drugs

1234.60

-10.90 (-0.88%)

< Home < Back

Dr. Reddy's Laboratories informs about press release

Date: 02-09-2021

Dr. Reddy's Laboratories has informed that it enclosed a Press Release on 2nd September 2021 titled ‘Dr. Reddy's Laboratories Canada announces the launch of Reddy-Lenalidomide, one of the first generic medications of its kind for the Canadian Market’.

The above information is a part of company’s filings submitted to BSE.